We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

132 hedge funds and large institutions have $337M invested in Precision BioSciences in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 43 increasing their positions, 36 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $2.17M | Put options by funds: $1M

29% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 14

19% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 36

2% more funds holding

Funds holding: 130 → 132 (+2)

0.03% less ownership

Funds ownership: 1.67% → 1.63% (-0.03%)

6% less capital invested

Capital invested by funds: $357M → $337M (-$20.5M)

Holders
132
Holders Change
+2
Holders Change %
+1.54%
% of All Funds
2.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
43
Reduced
36
Closed
14
Calls
$2.17M
Puts
$1M
Net Calls
+$1.17M
Net Calls Change
+$104K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$4.45M
2
JP Morgan Chase
JP Morgan Chase
New York
+$4.34M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.67M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.39M
5
N
Nuveen
North Carolina
+$3.34M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.47M
2
Morgan Stanley
Morgan Stanley
New York
-$4.29M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.12M
4
State Street
State Street
Massachusetts
-$2.86M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital World Investors
1
Capital World Investors
California
$49.3M – – –
BlackRock
2
BlackRock
New York
$48.3M +$3.1M +9,136 +7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$35.7M +$3.39M +10,005 +11%
State Street
4
State Street
Massachusetts
$29.2M -$2.86M -8,427 -9%
ACH
5
ArrowMark Colorado Holdings
Colorado
$25.9M -$1.41M -4,151 -5%
JP Morgan Chase
6
JP Morgan Chase
New York
$10.4M +$4.34M +12,801 +74%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$10.2M +$1.2M +3,540 +14%
Goldman Sachs
8
Goldman Sachs
New York
$7.61M +$4.45M +13,141 +149%
CA
9
CHI Advisors
New York
$7.46M -$56.3K -166 -0.8%
CS
10
Candriam SCA
Luxembourg
$7.31M – – –
Northern Trust
11
Northern Trust
Illinois
$5.97M -$90.8K -268 -2%
Principal Financial Group
12
Principal Financial Group
Iowa
$5.65M +$320K +943 +6%
N
13
Nuveen
North Carolina
$5.31M +$3.34M +9,865 +180%
Morgan Stanley
14
Morgan Stanley
New York
$4.34M -$4.29M -12,667 -50%
MSAM
15
Moloney Securities Asset Management
Missouri
$4.33M +$147K +433 +4%
CAM
16
Cormorant Asset Management
Massachusetts
$4M – – –
Charles Schwab
17
Charles Schwab
California
$3.85M +$177K +523 +5%
Millennium Management
18
Millennium Management
New York
$3.84M -$2.04M -6,014 -35%
Adage Capital Partners
19
Adage Capital Partners
Massachusetts
$3.75M +$3.67M +10,833 New
SCM
20
Sio Capital Management
New York
$2.97M -$410K -1,209 -12%
JAMONY
21
Jacob Asset Management of New York
California
$2.68M +$237K +700 +10%
Citadel Advisors
22
Citadel Advisors
Florida
$2.3M +$1.21M +3,560 +115%
Two Sigma Investments
23
Two Sigma Investments
New York
$2.21M +$451K +1,332 +26%
ACWM
24
Adams Chetwood Wealth Management
North Carolina
$2.08M – – –
Marshall Wace
25
Marshall Wace
United Kingdom
$2.08M +$2.03M +6,004 New
1
2 3 4 5

DTIL Hedge Fund Activity: Q3 2021 in Review

132 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2021, worth a combined $337M — down 5.7% from $357M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new DTIL positions and 14 closed out — a net gain of 4 holders — while 43 added to existing stakes and 36 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $4.45M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $7.47M sold.

  • 132 institutional investors held Precision BioSciences (DTIL) as of Q3 2021, up from 130 in Q2 2021.
  • Funds reported $337M of Precision BioSciences stock for Q3 2021, down 5.7% quarter-over-quarter.
  • 18 funds opened new Precision BioSciences positions in Q3 2021 and 14 closed out, a net change of +4 holders.
  • The largest Precision BioSciences buyer in Q3 2021 was Goldman Sachs, an estimated $4.45M added.
  • The largest Precision BioSciences seller in Q3 2021 was T. Rowe Price Associates, an estimated $7.47M sold.

Based on aggregated 13F filings for Q3 2021.